Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal. Health Technology Assessment 2009; 13(Suppl 3 Article 7): 43-48 Indexing Status Subject indexing assigned by NLM MeSH Adult; Anticoagulants /economics /therapeutic use; Arthroplasty, Replacement, Hip /adverse effects; Arthroplasty, Replacement, Knee /adverse effects; Cost-Benefit Analysiss; Morpholines /economics /therapeutic use; Postoperative Complications /economics /prevention & Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes /economics /therapeutic use; Venous Thromboembolism /economics /etiology /prevention & control; control Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence NETSCC, Health Technology Assessment, Alpha House, University of Southampton Science Park, Southampton, SO16 7NS UK Tel: +44 23 8059 5586 Email: hta@hta.ac.uk AccessionNumber 32013000636 Date abstract record published 19/08/2013 |